- Q2 2025 sales were €1.41 billion, down 4% year over year.
- Capital expenditures in Q2 2025 were €96 million, focusing on capacity expansion.
- Net cash flow for Q2 2025 was €-137 million, improved from €-179 million in Q2 2024.
- Polysilicon division expanded semiconductor-grade polysilicon capacity by over 50%.
Financial Performance
In Q2 2025, WACKER reported sales of €1.41 billion, a 4% decrease from the previous year, primarily due to a weaker US dollar and reduced sales volumes. EBITDA fell 26% to €114 million, impacted by lower sales and plant-utilization rates. The EBITDA margin was 8.1%, consistent with the prior quarter. Net income was negative at €-19 million, with earnings per share at €-0.49.
Regional Sales
WACKER generated 83% of its sales outside Germany. Sales in the Americas declined 5% to €261 million, while Europe saw a 2% increase to €581 million. In Asia, sales dropped 11% to €483 million.
Capital Expenditures and Cash Flow
Capital expenditures in Q2 2025 were €96 million, focusing on capacity expansion in various divisions. Net cash flow improved to €-137 million from €-179 million in Q2 2024, due to reduced inventory buildup in the Polysilicon division.
Business Divisions
The Silicones division saw a 1% sales decrease to €713 million, with EBITDA rising 16% to €104 million. Polymers sales fell 7% to €363 million, with a 32% drop in EBITDA to €40 million. Biosolutions sales declined 11% to €87 million, but EBITDA increased to €5 million. Polysilicon sales decreased 6% to €218 million, with a 39% drop in EBITDA to €34 million.
Outlook for 2025
WACKER revised its full-year forecast due to macroeconomic and geopolitical uncertainties, expecting sales between €5.5 billion and €5.9 billion, and EBITDA between €500 million and €700 million. The company anticipates a balanced net cash flow and lower capital expenditures.
